Adaptimmune Therapeutics PLC Business Operations Contracts & Agreements

16 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Termination and Transfer Agreement made and effective as of April 6, 2023 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Termination Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2023
Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain shareholders of Adaptimmune
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain stockholders of TCR2
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Amendment Agreement No. 8 made and effective as of December 19, 2022 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Collaboration and License Agreement, dated January 13, 2020, by and between Universal Cells, Inc. and Adaptimmune Limited
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Variation Agreement dated as of February 17, 2020 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Service Agreement dated as of February 17, 2020 by and between Adaptimmune Limited and Gavin Wood
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Agreement dated as of September 30, 2019 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Collaboration Agreement dated as of August 26, 2019 by and among Adaptimmune Limited and Noile-Immune Biotech, Inc
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Collaboration Agreement dated May 14, 2019 between Adaptimmune Limited and AIS Operating Co., Inc., f/k/a Alpine Immune Sciences, Inc
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Amendment Agreement No. 6, dated July 20, 2018 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Collaboration Agreement, dated January 5, 2018, between Adaptimmune Limited and Cell Therapy Catapult Limited
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Amendment Agreement No. 5, dated September 7, 2017 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
DATED 10 March 2017 (1) ADAPTIMMUNE THERAPEUTICS PLC and (2) J.J. NOBLE SERVICE AGREEMENT
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT by and between Merck Sharp & Dohme B.V., and Adaptimmune Limited Dated: October 27th, 2016
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2016
SERVICES AGREEMENT
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2016